{"disease":{"id":"management","name":"management"},"drugs":{"marketed":[{"drug_id":"desonide","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Verdeso","generic_name":"DESONIDE","company_name":"Padagis Us","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":"2800","mechanism":""},{"drug_id":"budesonide","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pulmicort Respules","generic_name":"BUDESONIDE","company_name":"AstraZeneca K.K.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":"2800","mechanism":""},{"drug_id":"fluticasone-propionate","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cutivate","generic_name":"FLUTICASONE PROPIONATE","company_name":"Teva Pharm","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":64,"revenue":"69.0","mechanism":""},{"drug_id":"metirosine","indication_name":"Management of inoperable pheochromocytoma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Demser","generic_name":"metirosine","company_name":"Aton Pharma Vpna","drug_phase":"marketed","molecular_target":"Tyrosine 3-monooxygenase","drug_class":"Catecholamine Synthesis Inhibitor [EPC]","quality_score":42,"revenue":null,"mechanism":""},{"drug_id":"methadone","indication_name":"Severe and Persistent Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadone Hydrochloride","generic_name":"METHADONE","company_name":"Specgx Llc","drug_phase":"marketed","molecular_target":"mu-opioid receptors, NMDA receptor","drug_class":"Opioid Agonist","quality_score":66,"revenue":null,"mechanism":"Methadone is a synthetic opioid that acts as a mu-agonist, providing analgesia and aiding in opioid addiction management."},{"drug_id":"haloperidol","indication_name":"Management of Psychotic Disorders","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Haldol","generic_name":"haloperidol","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 5A","drug_class":"Typical Antipsychotic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"levorphanol","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levo-Dromoran","generic_name":"LEVORPHANOL","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"mu-opioid receptor","drug_class":"Opioid Agonist","quality_score":64,"revenue":null,"mechanism":"Levorphanol binds primarily to mu-opioid receptors to produce analgesia, with no ceiling effect for pain relief."},{"drug_id":"pentazocine","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PENTAZOCINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"phentermine-and-topiramate","indication_name":"Obesity Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Phentermine and Topiramate","company_name":"VIVUS LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Phentermine and topiramate reduce appetite and food consumption through different mechanisms involving catecholamine release and neurotransmitter modulation."},{"drug_id":"phentermine-and-topiramate","indication_name":"Overweight with Comorbidity Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Phentermine and Topiramate","company_name":"VIVUS LLC","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Phentermine and topiramate reduce appetite and food consumption through different mechanisms involving catecholamine release and neurotransmitter modulation."},{"drug_id":"nalbuphine-hydrochloride","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NALBUPHINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"kappa opioid receptors, mu opioid receptors","drug_class":"","quality_score":60,"revenue":null,"mechanism":"Nalbuphine activates kappa opioid receptors and blocks mu opioid receptors."},{"drug_id":"oxymorphone","indication_name":"Acute Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Opana Er","generic_name":"OXYMORPHONE","company_name":"Endo","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"pentazocine-hydrochloride","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PENTAZOCINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"meperidine","indication_name":"Acute Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MEPERIDINE","company_name":"","drug_phase":"marketed","molecular_target":"mu-opioid receptor","drug_class":"opioid analgesic","quality_score":10,"revenue":null,"mechanism":"Meperidine is an opioid agonist that binds to mu-opioid receptors to produce analgesia and sedation."},{"drug_id":"nsaids-ibubrofen-aspirin","indication_name":"Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NSAIDs \"ibubrofen,Aspirin\"","company_name":"Assiut University","drug_phase":"marketed","molecular_target":"","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl1718","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"NALOXONE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"hydroxyzine-pamoate","indication_name":"Management of pruritus due to allergic conditions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HYDROXYZINE PAMOATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"factor-ix","indication_name":"Perioperative management of bleeding","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"factor ix","company_name":"National Heart, Lung, and Blood Institute (NHLBI)","drug_phase":"marketed","molecular_target":"coagulation Factor IX","drug_class":"","quality_score":55,"revenue":null,"mechanism":"REBINYN replaces missing coagulation Factor IX and slows its removal from circulation through PEGylation."},{"drug_id":"pegvaliase","indication_name":"Phenylketonuria (PKU) Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PEGVALIASE","company_name":"","drug_phase":"marketed","molecular_target":"phenylalanine","drug_class":"Phenylalanine Metabolizing Enzyme [EPC]","quality_score":10,"revenue":null,"mechanism":"Pegvaliase-pqpz converts phenylalanine to ammonia and trans-cinnamic acid, reducing blood phenylalanine levels in PKU patients."},{"drug_id":"xzp-5610-tablet-for-part-c2","indication_name":"Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"XZP-5610 Tablet for \"Part C2\"","company_name":"Xuanzhu Biopharmaceutical Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"ziconotide-acetate","indication_name":"Severe Chronic Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ZICONOTIDE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":32,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl2103744","indication_name":"Acute Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MORPHINE SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":18,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl2103744","indication_name":"Chronic Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MORPHINE SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":18,"revenue":null,"mechanism":null},{"drug_id":"torsemide","indication_name":"Hypertension Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TORSEMIDE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/K+/2Cl- carrier system","drug_class":"Loop Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Torsemide inhibits the Na+/K+/2Cl- carrier system in the thick ascending limb of the loop of Henle, leading to increased excretion of sodium, chloride, and water."},{"drug_id":"multiple-visit-corticosteroid-paste","indication_name":"Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Multiple-Visit-\"Corticosteroid Paste\"","company_name":"Istanbul Medipol University Hospital","drug_phase":"marketed","molecular_target":"cyclooxygenase (COX-1 and COX-2)","drug_class":"Nonsteroidal Anti-inflammatory Drug [EPC]","quality_score":45,"revenue":null,"mechanism":"Naproxen reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis through COX-1 and COX-2 inhibition."},{"drug_id":"belladonna-and-opium","indication_name":"Ureteral Spasm Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Belladonna and Opium","company_name":"University of Washington","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Belladonna/opium rectal suppository combines atropine and morphine to relax smooth muscles and increase pain threshold, respectively."},{"drug_id":"cromolyn","indication_name":"Management of mastocytosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CROMOLYN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"butorphanol-tartrate","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"BUTORPHANOL TARTRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"fluphenazine-hydrochloride","indication_name":"Management of psychotic disorders","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLUPHENAZINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"phendimetrazine-tartrate","indication_name":"Short-term weight management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHENDIMETRAZINE TARTRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"phendimetrazine-tartrate","indication_name":"Short-term weight management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHENDIMETRAZINE TARTRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"metyrosine","indication_name":"Management when surgery is contraindicated","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"METYROSINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Catecholamine Synthesis Inhibitor [EPC]","quality_score":25,"revenue":null,"mechanism":null},{"drug_id":"febuxostat-tablets","indication_name":"Chronic management of hyperuricemia in gout","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Febuxostat Tablets","company_name":"Mostafa Bahaa","drug_phase":"marketed","molecular_target":"","drug_class":"Xanthine Oxidase Inhibitor [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"ferulic-acid","indication_name":"Chronic weight management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ferulic Acid","company_name":"Salah Awad Alanazi","drug_phase":"marketed","molecular_target":"","drug_class":"Non-Standardized Chemical Allergen [EPC]","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"methylergonovine-maleate","indication_name":"Routine management of uterine atony","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"METHYLERGONOVINE MALEATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"alvesco","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Omnaris","generic_name":"Alvesco","company_name":"Takeda Gmbh","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"ciclesonide","quality_score":10,"revenue":null,"mechanism":"Omnaris works by activating the glucocorticoid receptor to reduce inflammation in the airways."},{"drug_id":"nedocromil","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Alocril","generic_name":"NEDOCROMIL","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"G-protein coupled receptor 35","drug_class":"Mast Cell Stabilizer","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"ciclesonide","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Omnaris","generic_name":"CICLESONIDE","company_name":"Covis","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"ciclesonide","quality_score":10,"revenue":null,"mechanism":"Omnaris works by binding to the glucocorticoid receptor, which then reduces inflammation in the airways."},{"drug_id":"cromoglicic-acid","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intal","generic_name":"cromoglicic acid","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G-protein coupled receptor 35","drug_class":"Mast Cell Stabilizer","quality_score":27,"revenue":null,"mechanism":""},{"drug_id":"fluticasone","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Flonase","generic_name":"fluticasone propionate","company_name":"GSK (GlaxoSmithKline)","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Inhaled/intranasal corticosteroid","quality_score":44,"revenue":null,"mechanism":""},{"drug_id":"cromoglicate","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cromoglicate","company_name":"LEO Pharma","drug_phase":"discontinued","molecular_target":"Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"beclometasone-dipropionate","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Beconase Aq","generic_name":"beclometasone dipropionate","company_name":"","drug_phase":"marketed","molecular_target":"Probable G-protein coupled receptor 97","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"flixotide","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Flixotide","company_name":"Mundipharma Research Limited","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"naloxone-hydrochloride","indication_name":"Management of pain severe enough to require an opioid analgesic","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naloxone Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Opioid receptors (mu, kappa)","drug_class":"Mixed opioid agonist-antagonist with opioid antagonist","quality_score":70,"revenue":null,"mechanism":"Pentazocine is a mixed agonist-antagonist at opioid receptors; naloxone is an opioid antagonist."},{"drug_id":"rhinocort","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rhinocort","company_name":"Marinomed Biotech AG","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"singulair","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Singulair","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C8, Adenosine receptor A3, Cysteinyl leukotriene receptor 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"diazepam-2mg-encapsulated-tab","indication_name":"Management of anxiety disorders","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diazepam 2Mg encapsulated Tab","company_name":"The University of Hong Kong","drug_phase":"marketed","molecular_target":"GABA-A receptor (allosteric modulator)","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"nasonex","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Nasonex","company_name":"University of Alberta","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Glucocorticoid receptor, Progesterone receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ethylnorepinephrine","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Butanefrine","generic_name":"ethylnorepinephrine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Butanefrine works by stimulating the body's natural responses to constrict blood vessels and increase airway resistance."},{"drug_id":"triamcinolone","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rodinolone","generic_name":"TRIAMCINOLONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"fluticason","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fluticason","company_name":"Creighton University","drug_phase":"marketed","molecular_target":"Cytosolic phospholipase A2, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"theophyllin","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Theophyllin","company_name":"University of Bergen","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"epinephrine","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"norepinephrine","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norepinephrine Bitartrate In 5% Dextrose","generic_name":"NOREPINEPHRINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"alpha-adrenergic receptors, beta-adrenergic receptors","drug_class":"Catecholamine","quality_score":80,"revenue":null,"mechanism":"Norepinephrine constricts blood vessels and stimulates the heart."},{"drug_id":"meperidine","indication_name":"Acute pain management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MEPERIDINE","company_name":"","drug_phase":"marketed","molecular_target":"mu-opioid receptor","drug_class":"opioid analgesic","quality_score":10,"revenue":null,"mechanism":"Meperidine is an opioid agonist that binds to mu-opioid receptors to produce analgesia and sedation."},{"drug_id":"flunisolide","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aerospan Hfa","generic_name":"FLUNISOLIDE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"flunisolide","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"benzhydrocodone","indication_name":"Short-term management of acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"BENZHYDROCODONE","company_name":"","drug_phase":"marketed","molecular_target":"Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways","drug_class":"Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic","quality_score":75,"revenue":null,"mechanism":"Benzhydrocodone is a hydrocodone prodrug providing mu-opioid receptor agonism combined with acetaminophen's central analgesic activity."},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"diprophylline","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diphyllin","generic_name":"diprophylline","company_name":"","drug_phase":"marketed","molecular_target":"cAMP-specific 3',5'-cyclic phosphodiesterase 4B","drug_class":"diprophylline","quality_score":35,"revenue":null,"mechanism":""},{"drug_id":"orciprenaline","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Metaproterenol","generic_name":"orciprenaline","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"mometasone-furoate","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Elocon","generic_name":"MOMETASONE FUROATE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Progesterone receptor","drug_class":"Corticosteroid","quality_score":75,"revenue":null,"mechanism":"Elocon works by binding to the progesterone receptor, which reduces inflammation and immune response in the body."},{"drug_id":"terbutaline","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brethine","generic_name":"TERBUTALINE","company_name":"","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"terbutaline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"zafirlukast","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Accolate","generic_name":"ZAFIRLUKAST","company_name":"Strides Pharma Intl","drug_phase":"marketed","molecular_target":"Cysteinyl leukotriene receptor 1","drug_class":"Leukotriene Receptor Antagonist [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"bitolterol","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tornalate","generic_name":"BITOLTEROL","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"bitolterol","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"beclometasone","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Beclometasone","company_name":"Imperial College London","drug_phase":"marketed","molecular_target":"Matrix metalloproteinase-9, Probable G-protein coupled receptor 97, Glucocorticoid receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrin","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"aminophyllin","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aminophyllin","company_name":"University of Padova","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"noradrenaline","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Noradrenaline","company_name":"Tanta University","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cromoglycate","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cromoglycate","company_name":"Vishwajit Nimgaonkar, MD PhD","drug_phase":"phase_3","molecular_target":"Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"montelukast","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Singulair","generic_name":"montelukast","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C8, Adenosine receptor A3, Cysteinyl leukotriene receptor 2","drug_class":"Leukotriene receptor antagonist (LTRA)","quality_score":null,"revenue":null,"mechanism":"Leukotriene receptor antagonist (LTRA) that blocks CysLT1 receptors, reducing bronchoconstriction, mucus production, and airway inflammation."},{"drug_id":"codeine","indication_name":"Mild to Moderate Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Codeine","generic_name":"codeine phosphate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Delta-type opioid receptor, Kappa-type opioid receptor, Mu-type opioid receptor","drug_class":"Opioid analgesic, Antitussive","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"mometasone","indication_name":"Asthma management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MOMETASONE","company_name":"","drug_phase":"discontinued","molecular_target":"Multidrug resistance protein 1, Glucocorticoid receptor, Progesterone receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":"12.1 Mechanism of Action Mometasone furoate nasal spray is a corticosteroid demonstrating potent anti-inflammatory properties. The precise mechanism of corticosteroid action on allergic rhinitis is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation. In two clinical studies utilizing nasal antigen challenge, mometasone furoate nasal spray decreased some markers of the early- and late-phase allergic response. These observations included decreases (vs. placebo) in histamine and eosinophil cationic protein levels, and reductions (vs. baseline) in eosinophils, neutrophils, and epithelial cell adhesion proteins. The clinical significance of these findings is not known. The effect of mometasone furoate nasal spray on nasal mucosa following 12 months of treatment was examined in 46 patients with allergic rhinitis. There was no evidence of atrophy and there was a marked reduction in intraepithelial eosinophilia and inflammatory cell infiltration (e.g., eosinophils, lymphocytes, monocytes, neutrophils, and plasma cells)."},{"drug_id":"hydromorphone","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dilaudid-Hp","generic_name":"HYDROMORPHONE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"mu-opioid receptor","drug_class":"Opioid Agonist","quality_score":66,"revenue":null,"mechanism":"Hydromorphone binds primarily to mu-opioid receptors, producing analgesia without a ceiling effect."},{"drug_id":"naloxone","indication_name":"Severe Pain Management","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":74,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04953845","title":"Artificial Intelligence System in Medical Regulation","phase":"","overall_status":"UNKNOWN","enrollment_count":500000,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT07308314","title":"Taining Golden Lake Comprehensive Chronic Disease Management Initiative","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"First Affiliated Hospital of Fujian Medical University","has_results":false},{"nct_id":"NCT06712264","title":"Construction and Effectiveness Evaluation of Painless Digestive Endoscopy Mode Led by Anesthesia Nurses Under the Guidance of Anesthesiologists","phase":"","overall_status":"COMPLETED","enrollment_count":18000,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT04449042","title":"The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry","phase":"","overall_status":"COMPLETED","enrollment_count":14835,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT07265037","title":"Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Shanxi Bethune Hospital","has_results":false},{"nct_id":"NCT07147413","title":"Digital Health Platform Blood Pressure Management Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06840236","title":"Digital Health Intervention On Awareness Of Vaccination Against Influenza Among Adults With Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":8431,"lead_sponsor_name":"LabStyle Innovations Ltd.","has_results":false},{"nct_id":"NCT07049861","title":"Advancing Biopsychosocial Care Training Initiative","phase":"NA","overall_status":"RECRUITING","enrollment_count":6200,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04744415","title":"Hospitalizations During Pandemia in the Italian Coronary Care Unit Network","phase":"","overall_status":"COMPLETED","enrollment_count":6054,"lead_sponsor_name":"Heart Care Foundation","has_results":false},{"nct_id":"NCT02993120","title":"Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States","phase":"","overall_status":"COMPLETED","enrollment_count":5006,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT04487977","title":"Survey on COVID-19 Airway Management","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Spanish Society of Anesthesia and Critical Care (SEDAR)","has_results":false},{"nct_id":"NCT07355608","title":"Videolaryngoscopic Difficult ıntubation and Glottic View Score: A Multicentre Prospective Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":4977,"lead_sponsor_name":"Diskapi Teaching and Research Hospital","has_results":false},{"nct_id":"NCT07289139","title":"Prehospital Emergency Airway Research.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4300,"lead_sponsor_name":"Centro de Emergencias Sanitarias 061 Andalucía","has_results":false},{"nct_id":"NCT06310148","title":"Evaluation of the Chronic Disease Co-Care Pilot Scheme","phase":"NA","overall_status":"RECRUITING","enrollment_count":3772,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT06073977","title":"Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation","phase":"","overall_status":"COMPLETED","enrollment_count":3750,"lead_sponsor_name":"Alper Kilicaslan","has_results":false},{"nct_id":"NCT05455073","title":"Evaluation of School-based Nutrition Intervention for Adolescents in Bangladesh","phase":"NA","overall_status":"COMPLETED","enrollment_count":3018,"lead_sponsor_name":"Nutrition International","has_results":false},{"nct_id":"NCT07485101","title":"Glycemic Targets During CPB in Elderly Diabetes","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT03009929","title":"Validation Study of ClassIntra®","phase":"","overall_status":"COMPLETED","enrollment_count":2500,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT02156778","title":"Post-Stroke Disease Management - Stroke Card","phase":"NA","overall_status":"COMPLETED","enrollment_count":2149,"lead_sponsor_name":"Medical University Innsbruck","has_results":false},{"nct_id":"NCT04176510","title":"Preventing Tipping Points in High Comorbidity Patients: A Lifeline From Health Coaches","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1920,"lead_sponsor_name":"Clinical Directors Network","has_results":false},{"nct_id":"NCT07248488","title":"Effect of an Intervention Combining the Use of Standardized Information and Sending an SMS Advice Message to Parents Calling the SAMU Center 15 for Uncomplicated Fever in Children","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1792,"lead_sponsor_name":"Centre Hospitalier Annecy Genevois","has_results":false},{"nct_id":"NCT07275567","title":"Data-driven Development of a Core Dataset for Difficult Airway Alerts","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1785,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT05149196","title":"Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy","phase":"NA","overall_status":"RECRUITING","enrollment_count":1724,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT02908373","title":"Risk Management in Nursing Homes","phase":"","overall_status":"COMPLETED","enrollment_count":1608,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT07139860","title":"Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction","phase":"","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Hui Chen","has_results":false},{"nct_id":"NCT07291544","title":"Management of Supraventricular Tachycardias in Children","phase":"","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Paris Cardiovascular Research Center (Inserm U970)","has_results":false},{"nct_id":"NCT07519122","title":"Fangshan Active Nutrition Initiative","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT04863846","title":"Evidence-based Algorithm for the Expected Difficult Intubation","phase":"","overall_status":"COMPLETED","enrollment_count":1282,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT06659965","title":"Intravenous Methocarbamol for Acute Pain After Spine Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":1270,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT02843113","title":"Stepping Up 4 Your Child","phase":"NA","overall_status":"COMPLETED","enrollment_count":1266,"lead_sponsor_name":"University of Louisville","has_results":false},{"nct_id":"NCT07382947","title":"MENSTRUATİON MANAGEMENT ACCORDİNG TO GENERATİONS","phase":"NA","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Batman University","has_results":false},{"nct_id":"NCT06703879","title":"Machine Learning-Based Model for Individualized Drug Dose Prediction for Propofol","phase":"","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"General Hospital of Ningxia Medical University","has_results":false},{"nct_id":"NCT06835335","title":"Opioid Prescribing in the Emergency Department for Sickle Cell Disease","phase":"","overall_status":"COMPLETED","enrollment_count":1063,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT07077317","title":"Examining the Effects of Anthropometric Measurements on Difficult Airway Prediction","phase":"","overall_status":"COMPLETED","enrollment_count":1044,"lead_sponsor_name":"Kutahya Health Sciences University","has_results":false},{"nct_id":"NCT07454993","title":"The Effect of Music During Colonoscopy","phase":"NA","overall_status":"RECRUITING","enrollment_count":1042,"lead_sponsor_name":"Esbjerg Hospital - University Hospital of Southern Denmark","has_results":false},{"nct_id":"NCT07524049","title":"Giving Children a Voice in Paediatric Anaesthesia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1040,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06842082","title":"The Videolaryngoscopy Versus Direct Laringoscopy for Residents Intubation Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1008,"lead_sponsor_name":"Hospital Universitario Lucus Augusti","has_results":false},{"nct_id":"NCT07464574","title":"Optimizing Non-statin Agents for ASCVD","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Texas at Austin","has_results":false},{"nct_id":"NCT07033871","title":"Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - Older Adults in China）","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Henan Provincial People's Hospital","has_results":false},{"nct_id":"NCT05315596","title":"Longitudinal Assessment of Pain-Related Patient-Reported Outcomes After Surgery","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1000,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT05223933","title":"Proactive Community Case Management (Pro-CCM) in Rural Madagascar","phase":"NA","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Institut Pasteur de Madagascar","has_results":false},{"nct_id":"NCT03532724","title":"Clinical Outcomes From Patient Self-management of Antivitamin K Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":927,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT05426863","title":"Domestic Violence Intervention to Reduce Psychological Distress and Violence Among Women Experiencing IPV in Nepal","phase":"NA","overall_status":"COMPLETED","enrollment_count":912,"lead_sponsor_name":"Global and Sexual Health (GloSH)","has_results":false},{"nct_id":"NCT06230445","title":"Effects of Digital Therapeutic in Whole Process Management of Lung Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05234216","title":"Comparison of a Comfort Scale and a Numerical Pain Scale on Opioid Consumption After Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":885,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT05488834","title":"Nurse-led Pain Management in Adult ICU","phase":"NA","overall_status":"COMPLETED","enrollment_count":880,"lead_sponsor_name":"King Abdulaziz Medical City","has_results":false},{"nct_id":"NCT06596889","title":"The Effect of Assistive Airway Equipment on Intubation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":870,"lead_sponsor_name":"Kocaeli City Hospital","has_results":false},{"nct_id":"NCT04844723","title":"Pediatric Videolaryngoscopic Intubation and Difficult Airway Classification","phase":"","overall_status":"COMPLETED","enrollment_count":809,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT06434545","title":"Symptom Management Essentials at Home","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT03641625","title":"Effect of SmtO2 Guided Care on PONV (iMODIPONV)","phase":"NA","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Yale University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}